Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-05 Purchase(A) | 2026-08-28 5:38 pm | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 585,000 | $17.58 | $10,285,000 | 3,392,705 (Indirect) | View |
| 2026-08-05 Sale(A) | 2026-08-28 5:38 pm | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 105,807 | $21.28 | $2,251,658 | 3,392,705 (Indirect) | View |
| 2026-08-05 Purchase | 2026-08-13 9:52 pm | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 585,000 | $17.58 | $10,285,000 | 3,020,632 (Indirect) | View |
| 2026-08-05 Sale | 2026-08-13 9:52 pm | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 105,807 | $21.28 | $2,251,658 | 3,020,632 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-06 Conversion(A) | 2026-08-28 5:38 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 25,062,737 | $0 | 3,392,705 (Indirect) | View |
| 2026-08-06 Conversion | 2026-08-13 9:52 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 25,062,737 | $0 | 3,020,632 (Indirect) | View |
Ownership | 2026-08-05 6:13 pm | N/A N/A | Attovia Therapeutics Inc. | ATTO | WALSH COLIN Director | 0 | $0 | 2,435,641 (Indirect) | View |
| 2023-06-16 Option Award | 2023-06-21 4:15 pm | N/A 2033-06-15 | Elevation Oncology Inc. | ELEV | Walsh Colin Director | 31,238 | $0 | 31,238 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 6:45 pm | N/A 2032-06-16 | Elevation Oncology Inc. | ELEV | Walsh Colin Director | 15,619 | $0 | 15,619 (Direct) | View |